# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Avid reported fourth quarter financial results on Tuesday after the market closed. The company reported a loss of $1.94 per sha...
RBC Capital analyst Sean Dodge reiterates Avid Bioservices (NASDAQ:CDMO) with a Outperform and maintains $8 price target.
Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(1.94) per share which missed the analyst consensus estimate of $(...
RBC Capital analyst Sean Dodge maintains Avid Bioservices (NASDAQ:CDMO) with a Outperform and raises the price target from $...